Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers.

STUDY

OBJECTIVE

To study the effect of intravenous (IV) sedation on blood pressure (BP), heart rate (HR), and respiratory rates (RR) to determine if IV sedatives differ with respect to their effect on BP, HR, and RR.

DESIGN

Prospective, randomized, single-blinded, placebo-controlled study.

SETTING

Monitored patient care room at a clinical research center.

SUBJECTS: 60 healthy ASA physical status 1 volunteers.

INTERVENTIONS: Subjects were randomized to receive, in increasing doses, one of three IV sedatives: propofol, midazolam, or dexmedetomidine; or saline control.

MEASUREMENTS: Blood pressure (systolic, diastolic), HR, and RR were recorded.

MAIN

RESULTS

A significant dose-dependent BP reduction occurred with dexmedetomidine and, to a lesser degree, with propofol; and there was good agreement of predicted versus measured drug concentrations for all sedatives. Blood pressure and HR of participants who received midazolam did not change.

CONCLUSIONS

When administered in sedative doses, dexmedetomidine and, to a lesser extent, midazolam, reduces BP in a dose-dependent fashion. Dexmedetomidine also reduces HR. Midazolam does not affect BP or HR.